Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alcoholic liver disease: Clinical and translational research.
Neuman MG, Malnick S, Maor Y, Nanau RM, Melzer E, Ferenci P, Seitz HK, Mueller S, Mell H, Samuel D, Cohen LB, Kharbanda KK, Osna NA, Ganesan M, Thompson KJ, McKillop IH, Bautista A, Bataller R, French SW. Neuman MG, et al. Among authors: ferenci p. Exp Mol Pathol. 2015 Dec;99(3):596-610. doi: 10.1016/j.yexmp.2015.09.001. Epub 2015 Sep 3. Exp Mol Pathol. 2015. PMID: 26342547 Review.
Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
Stättermayer AF, Traussnigg S, Aigner E, Kienbacher C, Huber-Schönauer U, Steindl-Munda P, Stadlmayr A, Wrba F, Trauner M, Datz C, Ferenci P. Stättermayer AF, et al. Among authors: ferenci p. J Trace Elem Med Biol. 2017 Jan;39:100-107. doi: 10.1016/j.jtemb.2016.08.006. Epub 2016 Aug 20. J Trace Elem Med Biol. 2017. PMID: 27908400
Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
Traussnigg S, Kienbacher C, Gajdošík M, Valkovič L, Halilbasic E, Stift J, Rechling C, Hofer H, Steindl-Munda P, Ferenci P, Wrba F, Trattnig S, Krššák M, Trauner M. Traussnigg S, et al. Among authors: ferenci p. Liver Int. 2017 Oct;37(10):1544-1553. doi: 10.1111/liv.13451. Epub 2017 May 20. Liver Int. 2017. PMID: 28544208 Free PMC article.
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
Paternostro R, Staufer K, Traussnigg S, Stättermayer AF, Halilbasic E, Keritam O, Meyer EL, Stift J, Wrba F, Sipos B, Canbay A, Schlattjan M, Aigner E, Datz C, Stickel F, Schafmayer C, Hampe J, Buch S, Prager G, Munda P, Mandorfer M, Ferenci P, Trauner M. Paternostro R, et al. Among authors: ferenci p. Hepatol Int. 2021 Aug;15(4):922-933. doi: 10.1007/s12072-021-10200-y. Epub 2021 Jun 2. Hepatol Int. 2021. PMID: 34076851 Free PMC article.
Wilson's Disease.
Ferenci P. Ferenci P. Clin Gastroenterol Hepatol. 2005 Aug;3(8):726-33. doi: 10.1016/s1542-3565(05)00484-2. Clin Gastroenterol Hepatol. 2005. PMID: 16233999 Review.
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
Mandorfer M, Payer BA, Schwabl P, Steiner S, Ferlitsch A, Aichelburg MC, Stättermayer AF, Ferenci P, Obermayer-Pietsch B, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T. Mandorfer M, et al. Among authors: ferenci p. Liver Int. 2015 Mar;35(3):876-85. doi: 10.1111/liv.12615. Epub 2014 Jun 26. Liver Int. 2015. PMID: 24905495
489 results